Z
Zachary J. Il'Giovine
Researcher at Cleveland Clinic
Publications - 11
Citations - 252
Zachary J. Il'Giovine is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 2, co-authored 10 publications receiving 72 citations.
Papers
More filters
Journal ArticleDOI
Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial.
Suma A. Thomas,Divyang Patel,Barbara Bittel,Kathy Wolski,Qiuqing Wang,Anirudh Kumar,Zachary J. Il'Giovine,Reena Mehra,Reena Mehra,Carla McWilliams,S E Nissen,Milind Y. Desai +11 more
TL;DR: In this paper, a randomized clinical trial of ambulatory patients diagnosed with SARS-CoV-2 infection, treatment with high-dose zinc gluconate, ascorbic acid, or a combination of the two supplements did not significantly decrease the duration of symptoms compared with standard of care.
Journal ArticleDOI
Acute Hemodynamic Effects of Sacubitril-Valsartan In Heart Failure Patients Receiving Intravenous Vasodilator and Inotropic Therapy
Trejeeve Martyn,Kathleen D. Faulkenberg,Chonyang L. Albert,Zachary J. Il'Giovine,Varinder K. Randhawa,Eoin Donnellan,Venu Menon,Jerry D. Estep,Steven E. Nissen,W.H. Wilson Tang,Randall C. Starling +10 more
TL;DR: In this article, the authors further characterize the hemodynamic impact of S/V after patients have been optimized on vasoactive therapy, and they show that patients in the cardiac intensive care unit can be successfully bridged from intravenous (i.v.) vasodilators or inotropes drugs to sacubitril-valsartan (S/V) with tolerance to the 1-month follow-up.
Journal ArticleDOI
The Intersection of Heart Failure and Critical Care: The Contemporary Cardiac Intensive Care Unit and the Opportunity for a Unique Training Pathway.
Zachary J. Il'Giovine,Venu Menon +1 more
Journal ArticleDOI
Kinetics of generic tacrolimus in heart transplantation: A cautionary note.
Zachary J. Il'Giovine,J. Bradley Williams,R. Preston Mason,Samuel C.R. Sherratt,Eileen Hsich,Harry M. Lever,Mandeep R. Mehra,Randall C. Starling +7 more
TL;DR: The authors compared active pharmaceutical ingredient (API) and dissolution kinetics of branded tacrolimus and formulations from three generic manufacturers (Mylan, Dr. Reddy's, Intas) including samples from patients who suffered acute cardiac allograft rejection.
Journal ArticleDOI
Attenuated heart rate recovery is associated with higher arrhythmia recurrence and mortality following atrial fibrillation ablation.
Eoin Donnellan,Oussama M. Wazni,Mina K. Chung,Mohamed B. Elshazly,Roy Chung,Tyler Taigen,Mark Niebauer,Arshneel Kochar,Muzna Hussain,Divyang Patel,Zachary J. Il'Giovine,Serge C. Harb,Daniel J. Cantillon,Mohamed Kanj,Walid Saliba,Wael A. Jaber +15 more
TL;DR: In this article, the authors investigated the association between attenuated HRR and outcomes following atrial fibrillation (AF) ablation and found that an impaired HRR is associated with significantly higher rates of arrhythmia recurrence and death following AF ablation.